Ptc Therapeutics (PTCT) EBT (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly EBT of $97.5 million for Q2 2026, up 237.29% year-over-year from $28.9 million in Q2 2025, and up 4062.02% quarter-over-quarter from -$2.5 million in Q1 2026.
Ptc Therapeutics (PTCT) EBT (2012 - 2026) Analysis & Trends
Ptc Therapeutics' EBT history runs 15 years deep, the most recent figure standing at $97.5 million for Q2 2026.
- In Q2 2026, EBT rose 237.29% year-over-year to $97.5 million; the TTM figure through Jun 2026 stood at $486.1 million (up 12.95% YoY), while the FY2025 annual figure was $1.2 billion, up 308.72% from the prior year.
- EBT for Q2 2026 stood at $97.5 million, up from -$2.5 million in the prior quarter.
- The five-year high for EBT was $929.8 million in Q1 2025, with the low at -$330.4 million in Q4 2024.
- The 5-year median for EBT is -$109.9 million (2022), against an average of -$35.0 million.
- The sharpest annual moves came in 2025 and 2026: EBT jumped 1197.84% in 2025, then tumbled 100.26% in 2026.
- Ptc Therapeutics' EBT stood at -$193.3 million in 2022, then decreased by 27.08% to -$245.7 million in 2023, then slumped by 34.48% to -$330.4 million in 2024, then soared by 225.34% to $414.1 million in 2025, then plunged by 76.44% to $97.5 million in 2026.
- Business Quant data shows PTCT's EBT at $97.5 million in Q2 2026, -$2.5 million in Q1 2026, and $414.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 97.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.55 Mn |
| Mar 31, 2026 | -2.46 Mn |
| Dec 31, 2025 | -139.08 Mn |
| Sep 30, 2025 | -23.07 Mn |
| Jun 30, 2025 | -71.05 Mn |
| Mar 31, 2025 | 929.83 Mn |
| Dec 31, 2024 | 504.11 Mn |
| Sep 30, 2024 | -97.99 Mn |
| Jun 30, 2024 | -85.73 Mn |
| Mar 31, 2024 | -84.70 Mn |
| Dec 31, 2023 | -245.69 Mn |
| Sep 30, 2023 | -166.59 Mn |
| Jun 30, 2023 | -237.48 Mn |
| Mar 31, 2023 | -134.99 Mn |
| Dec 31, 2022 | -193.33 Mn |
| Sep 30, 2022 | -127.21 Mn |
| Jun 30, 2022 | -148.70 Mn |
| Mar 31, 2022 | -121.89 Mn |
| Dec 31, 2021 | -138.61 Mn |
| Sep 30, 2021 | -133.66 Mn |